Lisa E. Paddock
- Dermatology top 2%
-
- Prostate Cancer Diagnosis and Treatment 23
- Prostate Cancer Treatment and Research 17
- Oncology top 5%
- Cancer survivorship and care 11
- Cancer Risks and Factors 6
- Urology top 5%
- Rheumatology top 10%
-
- Bladder and Urothelial Cancer Treatments 9
-
- Childhood Cancer Survivors' Quality of Life 8
-
- Health Systems, Economic Evaluations, Quality of Life 7
-
- BRCA gene mutations in cancer 6
- Co-authors
- Antoinette M. StroupXiao‐Cheng WuAnn S. HamiltonTatsuki KoyamaKaren E. HoffmanDavid F. PensonDaniel A. BarocasMichael Goodman
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Lisa E. Paddock
70 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Dermatology 244
- Pulmonary and Respiratory Medicine 802
- Oncology 625
- Urology 104
- Rheumatology 141
Countries citing papers authored by Lisa E. Paddock
This map shows the geographic impact of Lisa E. Paddock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Paddock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Paddock more than expected).
Fields of papers citing papers by Lisa E. Paddock
This network shows the impact of papers produced by Lisa E. Paddock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Paddock. The network helps show where Lisa E. Paddock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lisa E. Paddock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 54 | |
| 13 | 2018 | 13 | |
| 14 | 2018 | 20 | |
| 15 | 2017 | 47 | |
| 16 | 2017 | 21 | |
| 17 | 2016 | 19 | |
| 18 | 2015 | 80 | |
| 19 | 2014 | 10 | |
| 20 | 2011 | 27 |
About Lisa E. Paddock
Lisa E. Paddock is a scholar working on Oncology, General Arts and Humanities, Pulmonary and Respiratory Medicine, Applied Psychology and Reproductive Medicine, having authored 72 papers that have together received 1.9k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (17 papers), Cancer survivorship and care (11 papers), Bladder and Urothelial Cancer Treatments (9 papers), Childhood Cancer Survivors' Quality of Life (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer Risks and Factors (6 papers). The work is most often cited by research in Dermatology (244 citations), Pulmonary and Respiratory Medicine (802 citations), Oncology (625 citations), Urology (104 citations) and Rheumatology (141 citations). Lisa E. Paddock has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Antoinette M. Stroup, Xiao‐Cheng Wu, Ann S. Hamilton, Tatsuki Koyama, Karen E. Hoffman, David F. Penson, Daniel A. Barocas, Michael Goodman, Sheldon Greenfield and Matthew R. Cooperberg. Their work appears in journals such as The Journal of Urology, European Urology, Cancer, Journal of Cancer Survivorship and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.